We are live on ! Find out more
VBIV

VBI Vaccines, Inc. New Common Stock (Canada)
VBIV

Delisted

VBIV was delisted on the 7th of August, 2024.

Back to rankings

6 hedge funds and large institutions have $422K invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more funds holding

Funds holding: 5 → 6 (+1)

17% more capital invested

Capital invested by funds: $360K → $422K (+$62K)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$149K
2
WS
Wedbush Securities
California
+$3.1K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$619

VBIV Hedge Fund Activity: Q2 2014 in Review

6 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q2 2014, worth a combined $422K — up 17% from $360K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new VBIV positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $149K. The largest seller was Citadel Advisors, cutting an estimated $619.

  • 6 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q2 2014, up from 5 in Q1 2014.
  • Funds reported $422K of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q2 2014, up 17% quarter-over-quarter.
  • 1 fund opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q2 2014 and 0 closed out, a net change of +1 holder.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q2 2014 was Hudson Bay Capital Management, an estimated $149K added.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q2 2014 was Citadel Advisors, an estimated $619 sold.

Based on aggregated 13F filings for Q2 2014.